This mid-cap multibagger Pharma company signs MOA with IIT Kanpur for novel gene therapy assets!
This mid-cap multibagger Pharma company signs MOA with IIT Kanpur for novel gene therapy assets!

This mid-cap multibagger Pharma company signs MOA with IIT Kanpur for novel gene therapy assets!

The company delivered exceptional returns of 251 per cent over the past 3 years.

Siddharth Mane Article rating: 3.8

The company delivered exceptional returns of 251 per cent over the past 3 years, while over the past 5 years, it provided remarkable returns of 242 per cent.    

This multibagger tech company partners with FundMore to deliver compliance automation solutions for mortgage lenders in Canada!
This multibagger tech company partners with FundMore to deliver compliance automation solutions for mortgage lenders in Canada!

This multibagger tech company partners with FundMore to deliver compliance automation solutions for mortgage lenders in Canada!

The company has a ROCE of 31.6 per cent and a ROE of 25.1 per cent.

Siddharth Mane Article rating: 3.8

The company gave great returns of 36 per cent over the past 1 year and stellar returns of 235 per cent over the past 3 years. Moreover, it has a healthy dividend payout ratio of 40.1 per cent.   

This mid-cap multibagger company invests in cell and gene therapy company ImmunoACT!
This mid-cap multibagger company invests in cell and gene therapy company ImmunoACT!

This mid-cap multibagger company invests in cell and gene therapy company ImmunoACT!

Through this collaboration, the company aims to bring CAR-T therapy to Indian patients at an affordable price, filling the gap in access to this novel treatment option.

Siddharth Mane Article rating: 3.3

CAR-T therapy has shown significant success in the western world as a promising treatment option. However, this innovative technology is currently unavailable in India. Through this collaboration, the company aims to bring CAR-T therapy to Indian patients at an affordable price, filling the gap in access to this novel treatment option. 

430 per cent returns: This multibagger telecom stock announces robust expansion plans for optic fiber business!
430 per cent returns: This multibagger telecom stock announces robust expansion plans for optic fiber business!

430 per cent returns: This multibagger telecom stock announces robust expansion plans for optic fiber business!

A leading technology enterprise in India has announced the expansion of its optical fiber manufacturing capacity from 10 million fiber km/per annum to 33.90 million fiber km/per annum.

Siddharth Mane Article rating: 3.8

The company delivers innovative digital network solutions, including premium quality optical fiber, telecom products like 5G RAN and transport, Wi-Fi systems, radios, switches, routers and software-defined radios. 

This cement company announces a capex of Rs 3,642 crore!
This cement company announces a capex of Rs 3,642 crore!

This cement company announces a capex of Rs 3,642 crore!

The company has an impressive CAGR of 83 per cent on its profits over the span of 3 years, while also maintaining a solid 40 per cent CAGR over the past 5 years.

Siddharth Mane Article rating: 3.6

Dalmia Bharat has approved a capital expenditure of Rs 3,642 crore.

RSS
1234

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR